- Home
- IMRX vs EMF Comparison
IMRX vs EMF Comparison
Compare IMRX & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- EMF
- Stock Information
- Founded
- IMRX 2008
- EMF 1987
- Country
- IMRX United States
- EMF United States
- Employees
- IMRX N/A
- EMF N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- EMF Finance/Investors Services
- Sector
- IMRX Health Care
- EMF Finance
- Exchange
- IMRX Nasdaq
- EMF Nasdaq
- Market Cap
- IMRX 232.9M
- EMF 254.5M
- IPO Year
- IMRX 2021
- EMF N/A
- Fundamental
- Price
- IMRX $6.49
- EMF $17.46
- Analyst Decision
- IMRX Strong Buy
- EMF
- Analyst Count
- IMRX 4
- EMF 0
- Target Price
- IMRX $17.75
- EMF N/A
- AVG Volume (30 Days)
- IMRX 1.9M
- EMF 29.3K
- Earning Date
- IMRX 11-12-2025
- EMF 01-01-0001
- Dividend Yield
- IMRX N/A
- EMF 6.16%
- EPS Growth
- IMRX N/A
- EMF N/A
- EPS
- IMRX N/A
- EMF N/A
- Revenue
- IMRX N/A
- EMF N/A
- Revenue This Year
- IMRX N/A
- EMF N/A
- Revenue Next Year
- IMRX N/A
- EMF N/A
- P/E Ratio
- IMRX N/A
- EMF N/A
- Revenue Growth
- IMRX N/A
- EMF N/A
- 52 Week Low
- IMRX $1.10
- EMF $10.58
- 52 Week High
- IMRX $10.08
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- IMRX 51.11
- EMF 67.50
- Support Level
- IMRX $5.23
- EMF $16.82
- Resistance Level
- IMRX $6.44
- EMF $17.19
- Average True Range (ATR)
- IMRX 0.44
- EMF 0.33
- MACD
- IMRX -0.00
- EMF 0.02
- Stochastic Oscillator
- IMRX 71.58
- EMF 98.57
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.